Nov 19, 2024
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - Nippon India Pharma Fund (Bonus) | -4.56 | 14.93 | 35.69 | 18.27 |
| Benchmark - S&P BSE Healthcare | 14.73 | 38.57 | 53.75 | 13.45 |
| Category Average - BEST EQUITY PERFORMERS | -5.9 | 6.66 | 30.15 | 16.56 |
| Category Rank | 7/7 | 7/7 | 6/7 | 7/7 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund (IDCW) | 11.4604 | 2.98 | 25.58 | 0.00 | 0.00 | 364.14 | 2.43 | 500.00 | invest |
| Nippon India Taiwan Equity Fund (G) | 11.4604 | 2.98 | 25.58 | 0.00 | 0.00 | 364.14 | 2.43 | 500.00 | invest |
| SBI Automotive Opportunities Fund - Regular (G) | 9.6655 | 1.62 | 0.00 | 0.00 | 0.00 | 6,003.23 | 1.79 | 5,000.00 | invest |
| SBI Automotive Opportunities Fund - Regular (IDCW) | 9.6656 | 1.62 | 0.00 | 0.00 | 0.00 | 6,003.23 | 1.79 | 5,000.00 | invest |
| SBI Energy Opportunities Fund - Regular (G) | 10.1076 | -0.49 | 0.00 | 0.00 | 0.00 | 10,889.77 | 1.72 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Oct 31, 2024 | 1,212.20 | 13.95 | -4.04 |
|
| Equity-Divi`s Lab. | Oct 31, 2024 | 795.58 | 9.16 | 8.20 |
|
| Equity-Lupin | Oct 31, 2024 | 700.63 | 8.06 | -0.19 |
|
| Equity-Cipla | Oct 31, 2024 | 481.04 | 5.54 | -6.19 |
|
| Equity-Apollo Hospitals | Oct 31, 2024 | 455.63 | 5.24 | -2.45 |
|
| Equity-Dr Reddy`s Labs | Oct 31, 2024 | 445.99 | 5.13 | -5.64 |
|
| Reverse Repo-TREPS | Oct 31, 2024 | 385.64 | 4.44 | 13.59 |
|
| Equity-Vijaya Diagnost. | Oct 31, 2024 | 302.31 | 3.48 | 4.10 |
|
| Equity-Ajanta Pharma | Oct 31, 2024 | 294.00 | 3.38 | -4.28 |
|
| Equity-J B Chemicals & | Oct 31, 2024 | 250.78 | 2.89 | 4.59 |
|
Nippon India Mutual Fund has announced 14 November 2024 as the record date ...
Nippon India Mutual Fund has announced change in exit load structure under ...
Nippon India Mutual Fund has announced 15 October 2024 as the record date f...
Nippon India Mutual Fund has approved the merger of Nippon India ETF Nifty ...
Groww Mutual Fund has announced change in exit load structure under followi...
Nippon India Mutual Fund has announced change in Fund Managers of the follo...
| AMC Name | : | Nippon India Mutual Fund |
| Fund Name | : | Nippon India Pharma Fund (Bonus) |
| Contact Persone | : | Sailesh Raj Bhan |
| Registered Address | : | 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013. |
| Telephone No | : | 022-68087000/1860260111 |
| Fax No. | : | 022-68087097 |
| : | customercare:nipponindiaim.in | |
| Website | : | mf.nipponindiaim.com |
Top Mutual Funds
